Starpharma Holdings (SPL)

Stock Code


Stock Exchange


Starpharma Holdings (SPL) is a world leading developer of nanotechnology-based pharmaceuticals operating in Australia and United States. The Company develops and commercialises dendrimer products for use in pharmaceutical, life-science and other applications. SPL is engaged in the development of nano-scale materials, with a particular focus on the development of topical vaginal microbicides to prevent transmission of genital herpes and human immunodeficiency virus (HIV). The key product brand of the Company is VivaGel, which is the most advanced product included in its pipeline.

Starpharma Holdings Dividends

1 September, 2010 - 13:40

Learn the dividend history for STARPHARMA HOLDINGS LIMITED. Dividends are a payment declared by a company's board of directors and given to its shareholders from the company's current or retained earnings. Dividends are usually released as cash (cash dividend). Dividends provide an incentive to own shares in the company. Companies are not required to pay dividends. You are eligible to receive SPL dividends if you own the STARPHARMA HOLDINGS LIMITED shares on the ex-dividend date.

Syndicate content

Recommended Websites